Biotechnology Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference March 16, 2022
Biotechnology Apellis Announces Pegcetacoplan Showed Continuous and Clinically Meaningful Effects at Month 18 in Phase 3 DERBY and OAKS Studies for Geographic Atrophy (GA) March 16, 2022
Biotechnology Moore Kuehn, PLLC Encourages Investors of Reata Pharmaceuticals, Inc. to Contact Law Firm March 15, 2022
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beigene, Ltd. – BGNE March 15, 2022
Biotechnology Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults March 15, 2022
Biotechnology Denali Therapeutics Appoints Alexander Schuth as Chief Operating and Financial Officer as Steve Krognes Transitions to Denali Board of Directors March 15, 2022